Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Richard A Hubner

Showing results (61-70 of 106) with videos related to

Pageof 11
Sort By:
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|November 7, 2006
Genetic variants of UGT1A6 influence risk of colorectal adenoma recurrenceRichard A Hubner, Kenneth R Muir, Jo-Fen Liu, et al.
Cancer Treatment Reviews|November 5, 2023
Resistance mechanism to fibroblast growth factor receptor (FGFR) inhibitors in cholangiocarcinomaAngela Lamarca, Lorena Ostios, Mairéad G McNamara, et al.
Cancer Treatment Reviews|September 28, 2016
Post-gemcitabine therapy for patients with advanced pancreatic cancer - A comparative review of randomized trials evaluating oxaliplatin- and/or irinotecan-containing regimensArndt Vogel, Fortunato Ciardiello, Richard A Hubner, et al.
Cancers|June 10, 2023
Third-Line Palliative Systemic Therapy for Advanced Biliary Tract Cancer: Multicentre Review of Patterns of Care and OutcomesSimon Gray, Octave Letissier, Constance d'Abrigeon, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|September 21, 2006
Folate metabolism polymorphisms influence risk of colorectal adenoma recurrenceRichard A Hubner, Kenneth R Muir, Jo-Fen Liu, et al.
Expert Review of Gastroenterology & Hepatology|June 21, 2018
Somatostatin analogue-induced pancreatic exocrine insufficiency in patients with neuroendocrine tumors: results of a prospective observational studyAngela Lamarca, Lynne McCallum, Christina Nuttall, et al.
British Journal of Cancer|October 9, 2023
Influence of cirrhosis on outcomes of patients with advanced intrahepatic cholangiocarcinoma receiving chemotherapyConstance d'Abrigeon, Mairéad G McNamara, Samuel Le Sourd, et al.
World Journal of Gastrointestinal Oncology|February 22, 2019
Identification of patients with pancreatic adenocarcinoma due to inheritable mutation: Challenges of daily clinical practiceAlexander Jp Fulton, Angela Lamarca, Christina Nuttall, et al.
International Journal of Molecular Sciences|April 27, 2017
Targeting the Epidermal Growth Factor Receptor in Addition to Chemotherapy in Patients with Advanced Pancreatic Cancer: A Systematic Review and Meta-AnalysisJaseela Chiramel, Alison C Backen, Rille Pihlak, et al.
European Journal of Cancer (Oxford, England : 1990)|November 2, 2018
Sorafenib as first-line therapy in patients with advanced Child-Pugh B hepatocellular carcinoma-a meta-analysisMairéad Geraldine McNamara, Astrid E Slagter, Christina Nuttall, et al.
Pageof 11

Showing results (61-70 of 106) with videos related to

Sort By:
Pageof 11
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|November 7, 2006
Genetic variants of UGT1A6 influence risk of colorectal adenoma recurrenceRichard A Hubner, Kenneth R Muir, Jo-Fen Liu, et al.
Cancer Treatment Reviews|November 5, 2023
Resistance mechanism to fibroblast growth factor receptor (FGFR) inhibitors in cholangiocarcinomaAngela Lamarca, Lorena Ostios, Mairéad G McNamara, et al.
Cancer Treatment Reviews|September 28, 2016
Post-gemcitabine therapy for patients with advanced pancreatic cancer - A comparative review of randomized trials evaluating oxaliplatin- and/or irinotecan-containing regimensArndt Vogel, Fortunato Ciardiello, Richard A Hubner, et al.
Cancers|June 10, 2023
Third-Line Palliative Systemic Therapy for Advanced Biliary Tract Cancer: Multicentre Review of Patterns of Care and OutcomesSimon Gray, Octave Letissier, Constance d'Abrigeon, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|September 21, 2006
Folate metabolism polymorphisms influence risk of colorectal adenoma recurrenceRichard A Hubner, Kenneth R Muir, Jo-Fen Liu, et al.
Expert Review of Gastroenterology & Hepatology|June 21, 2018
Somatostatin analogue-induced pancreatic exocrine insufficiency in patients with neuroendocrine tumors: results of a prospective observational studyAngela Lamarca, Lynne McCallum, Christina Nuttall, et al.
British Journal of Cancer|October 9, 2023
Influence of cirrhosis on outcomes of patients with advanced intrahepatic cholangiocarcinoma receiving chemotherapyConstance d'Abrigeon, Mairéad G McNamara, Samuel Le Sourd, et al.
World Journal of Gastrointestinal Oncology|February 22, 2019
Identification of patients with pancreatic adenocarcinoma due to inheritable mutation: Challenges of daily clinical practiceAlexander Jp Fulton, Angela Lamarca, Christina Nuttall, et al.
International Journal of Molecular Sciences|April 27, 2017
Targeting the Epidermal Growth Factor Receptor in Addition to Chemotherapy in Patients with Advanced Pancreatic Cancer: A Systematic Review and Meta-AnalysisJaseela Chiramel, Alison C Backen, Rille Pihlak, et al.
European Journal of Cancer (Oxford, England : 1990)|November 2, 2018
Sorafenib as first-line therapy in patients with advanced Child-Pugh B hepatocellular carcinoma-a meta-analysisMairéad Geraldine McNamara, Astrid E Slagter, Christina Nuttall, et al.
Pageof 11